Opus Genetics (IRD) Cash from Financing Activities (2011 - 2026)
Opus Genetics (IRD) reported Cash from Financing Activities of $27.6 million for Q1 2026, up 34.84% year-over-year from $20.5 million in Q1 2025, and up 14.46% on a QoQ basis from $24.1 million in Q4 2025.
Opus Genetics (IRD) has 14 years of Cash from Financing Activities data on file, last reported at $27.6 million in Q1 2026.
- Quarterly Cash from Financing Activities rose 34.84% year-over-year to $27.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.2 million (up 156.58% YoY) and the FY2025 annual result came in at $50.0 million, up 1095.01% from the prior year.
- Cash from Financing Activities improved to $27.6 million in Q1 2026 per IRD's latest filing, from $24.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $27.6 million in Q1 2026 and bottomed at -$83000.0 in Q4 2024.
- The 5-year median for Cash from Financing Activities is $1.6 million (2022), against an average of $6.3 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities soared 30125.0%; it then slumped 102.3% in 2024.
- Tracing IRD's Cash from Financing Activities over 5 years: stood at -$12000.0 in 2022, then soared by 30125.0% to $3.6 million in 2023, then plunged by 102.3% to -$83000.0 in 2024, then soared by 29146.99% to $24.1 million in 2025, then rose by 14.46% to $27.6 million in 2026.
- Per Business Quant, the three latest IRD Cash from Financing Activities figures stand at $27.6 million (Q1 2026), $24.1 million (Q4 2025), and $4.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 27.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.60 Mn |
| Mar 31, 2026 | 27.60 Mn |
| Dec 31, 2025 | 24.11 Mn |
| Dec 31, 2025 | 24.11 Mn |
| Sep 30, 2025 | 4.54 Mn |
| Sep 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | 906,000.00 |
| Jun 30, 2025 | 906,000.00 |
| Mar 31, 2025 | 20.47 Mn |
| Mar 31, 2025 | 20.47 Mn |
| Dec 31, 2024 | -83,000.00 |
| Dec 31, 2024 | -83,000.00 |
| Sep 30, 2024 | 353,000.00 |
| Sep 30, 2024 | 353,000.00 |
| Jun 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Mar 31, 2024 | 2.38 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 5.38 Mn |
| Sep 30, 2023 | 5.38 Mn |
| Dec 31, 2022 | -12,000.00 |
| Dec 31, 2022 | -12,000.00 |
| Sep 30, 2022 | 1.33 Mn |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 1.59 Mn |
| Jun 30, 2022 | 1.59 Mn |
| Mar 31, 2022 | 882,000.00 |
| Mar 31, 2022 | 882,000.00 |
| Dec 31, 2021 | 8.03 Mn |
| Dec 31, 2021 | 8.03 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 17.97 Mn |
| Jun 30, 2021 | 17.97 Mn |
| Mar 31, 2021 | 10,000.00 |
| Mar 31, 2021 | 10,000.00 |
| Dec 31, 2020 | 19.50 Mn |
| Dec 31, 2020 | 19.50 Mn |
| Sep 30, 2020 | 924,000.00 |
| Sep 30, 2020 | 924,000.00 |
| Jun 30, 2020 | 252,000.00 |
| Jun 30, 2020 | 252,000.00 |
| Mar 31, 2020 | 448,000.00 |
| Mar 31, 2020 | 448,000.00 |
| Dec 31, 2019 | -2.95 Mn |
| Dec 31, 2019 | -2.95 Mn |
| Mar 31, 2019 | 7.65 Mn |
| Mar 31, 2019 | 7.65 Mn |
| Dec 31, 2017 | 7.44 Mn |
| Dec 31, 2017 | 7.44 Mn |
| Sep 30, 2017 | -113,731.00 |
| Sep 30, 2017 | -113,731.00 |
| Jun 30, 2017 | 12.42 Mn |
| Jun 30, 2017 | 12.42 Mn |
| Mar 31, 2017 | 2.37 Mn |
| Mar 31, 2017 | 2.37 Mn |
| Sep 30, 2016 | 5.54 Mn |
| Sep 30, 2016 | 5.54 Mn |
| Mar 31, 2016 | 4.58 Mn |
| Mar 31, 2016 | 4.58 Mn |
| Dec 31, 2015 | 6.43 Mn |
| Dec 31, 2015 | 6.43 Mn |
| Sep 30, 2015 | 22,325.00 |
| Sep 30, 2015 | 22,325.00 |
| Jun 30, 2015 | 1.01 Mn |
| Jun 30, 2015 | 1.01 Mn |
| Mar 31, 2015 | 705,542.00 |
| Mar 31, 2015 | 705,542.00 |
| Jun 30, 2014 | 907,705.00 |
| Jun 30, 2014 | 907,705.00 |
| Mar 31, 2014 | 23.93 Mn |
| Mar 31, 2014 | 23.93 Mn |
| Dec 31, 2013 | 5.76 Mn |
| Dec 31, 2013 | 5.76 Mn |
| Sep 30, 2013 | 6.56 Mn |
| Sep 30, 2013 | 6.56 Mn |
| Dec 31, 2011 | 19,200.00 |
| Dec 31, 2011 | 19,200.00 |
| Sep 30, 2011 | 22,040.00 |
| Sep 30, 2011 | 22,040.00 |
| Mar 31, 2011 | 13.56 Mn |
| Mar 31, 2011 | 13.56 Mn |